Ennature Biopharma, a leading science backed ingredient manufacturer recently subjected its two women health botanical ingredients Aspargize™ and Gingeren™ to the Alkemist Assured program.
The Alkemist Assured™ program from Alkemist Lab (CA) is widely recognized for its stringent botanical authentication protocols, helping ensure that branded ingredients meet the highest standards for authenticity and safety in the global nutraceutical market. After undergoing the rigorous testing program, we are proud to say that Aspargize™ and Gingeren™ have the Alkemist Assured™ Botanical Certification.
The Alkemist Assured™ certification positions Aspargize™ and Gingeren™ among a select group of independently verified botanical ingredients, providing supplement
manufacturers and healthcare professionals with confidence in their authenticity, quality, and clinically demonstrated performance.
Aspargize™, a fast-acting Shatavari extract, demonstrated superior efficacy in improving multiple menopausal symptoms — including hot flashes, sleep disturbances, mood instability, and stress — with measurable improvements observed as early as 2 weeks. Clinical outcomes included:
- 58% reduction in hot flashes
- 58% Improvement in Mood
- 32% Improvement in Sleep Quality
- 27% Reduction in Stress Levels
Gingeren™, a long-acting ginger extract developed for menstrual health support, showed significant clinical benefits among women with primary dysmenorrhea, including:
- Up to 68% reduction in menstrual pain intensity
- 74% improvement in daily functioning and work productivity during menstrual cycles
- 64% reduction in total days with pain, enabling a meaningful transition from moderate discomfort to manageable symptom levels
Administered by ISO 17025-accredited Alkemist Labs, the Alkemist Assured™ program independently verifies botanical identity, authenticity, purity, and label claim compliance through rigorous analytical testing. The certification reinforces ingredient integrity and provides manufacturers with trusted assurance of quality.
